Latest news
IBRX Stock Rises Overnight: Investors Eye FDA Workshop On Anktiva After Exclusive Japan BCG Deal - StocktwitsStocktwits · Sat, 08 Aug 2026 08:26:22 GMTIBRX Stock Eyes Green Open Ahead Of Earnings — What Happened With Anktiva Over The Weekend - StocktwitsStocktwits · Fri, 07 Aug 2026 17:00:28 GMTIBRX Stock Extends 5-Day Losing Streak — Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat - StocktwitsStocktwits · Fri, 07 Aug 2026 15:44:53 GMTIBRX Stock Reverses Pre-Market Gains After ANKTIVA Combo Shows Stronger Bladder Cancer Responses – Retail Sees Consolidation Before Next Leg Up - StocktwitsStocktwits · Fri, 07 Aug 2026 14:30:08 GMTIBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week - StocktwitsStocktwits · Fri, 07 Aug 2026 14:26:19 GMTIBRX Stock Extends Rally: Founder Flags Fresh Bull Case For Anktiva On Breast Cancer Immune Signal - StocktwitsStocktwits · Fri, 07 Aug 2026 13:12:20 GMTIBRX Founder Backs Trump’s Psychedelic Push In ‘Transforming’ Health Policy — Flags New Anktiva Breast Cancer Risk Data - StocktwitsStocktwits · Fri, 07 Aug 2026 11:57:05 GMTIBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU - StocktwitsStocktwits · Fri, 07 Aug 2026 11:34:22 GMT